AssetMark Inc
BIVV

AssetMark Inc’s Bioverativ Inc. Common Stock BIVV Stock Holding History

AssetMark Inc’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-70
Closed -$4K – 2264
2017
Q4 		$4K Sell
70
-47
-40% -$2.57K ﹤0.01% 1325
2017
Q3 		$7K Buy
117
+28
+31% +$1.64K ﹤0.01% 1108
2017
Q2 		$5K Sell
89
-6
-6% -$342 ﹤0.01% 1124
2017
Q1 		$5K Buy
+95
New +$4.68K ﹤0.01% 1040

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

AssetMark Inc's BIVV Position: Q1 2018 in Review

AssetMark Inc sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 70 shares — an estimated $4K sold.

AssetMark Inc first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • AssetMark Inc reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • AssetMark Inc sold 70 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $4K.
  • AssetMark Inc first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • AssetMark Inc's Bioverativ Inc. Common Stock position peaked at $7K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on AssetMark Inc's 13F filing for Q1 2018, filed 16 May 2018.